Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMUNE in Pediatric HIV/AIDS
NCT02291809Phase 2Unknown
- Sponsor
- Immune Response BioPharma, Inc.
- Start
- Nov 2017
- Primary completion
- Nov 2019
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Remune in human immunodeficiency virus infection (HIV), sponsored by Immune Response BioPharma, Inc.. Status: unknown.
02
Drugs
Remune
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02291809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291809.